Assessment of synergistic effect of combining hyperthermia with irradiation and calcium carbonate nanoparticles on proliferation of human breast adenocarcinoma cell line (MCF-7 cells)
Source abstract
Abstract
The present study was undertaken to evaluate the synergistic effect of combining hyperthermia with irradiation and calcium carbonate nanoparticles (CC NPs) on proliferation of MCF-7 cells. The cells were randomly allocated to 19 groups: one negative control, three positive controls and 15 treatment groups. MCF-7 cells were treated with three concentrations of CC NPs (50, 100 and 150 μg/mL), gamma radiation (200 cGy), hyperthermia (41 °C for 1 h) and three concentrations of doxorubicin (200, 400 and 800 nm) and incubated at 37 °C for 24 h. Then the cell viability, the percentage of apoptosis and the levels of caspase-3, -8 and -9 proteins were measured. The results indicated that the combination group (150 µg/mL CC NPs + thermoradiotherapy) had a significant (p < .001) decrease in cell viability (48.65 ± 4.8%) and a significant (p < .001) increase in apoptosis percentage (45 ± 1.63%) of MCF-7 cells, as compared with the negative control and most of the other treatment groups. Moreover, a significant (p < .05) increase was observed in the activity of caspase-3 and caspase-9. Our findings revealed that CC NPs in combination with irradiation and hyperthermia could significantly reduce the cell viability and enhance the apoptosis of the MCF-7 breast cancer cells, the same as doxorubicin anti-cancer drug.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Radiation Therapy and Dosimetry · Ultrasound and Hyperthermia Applications · Effects of Radiation Exposure
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran
References (44)
Show source-provided references
1. 10.1200/JCO.2013.54.225810.1200/JCO.2013.54.2258 ↗
2. 10.1016/j.clon.2005.11.01110.1016/j.clon.2005.11.011 ↗
3. 10.1371/journal.pone.015882810.1371/journal.pone.0158828 ↗
4. 10.3322/caac.2120910.3322/caac.21209 ↗
5. 10.3390/cancers303327910.3390/cancers3033279 ↗
6. 10.4155/tde.11.7210.4155/tde.11.72 ↗
7. Hall EJ · 2011
8. Jabir NR · Int J Nanomedicine · 2012 · 7 · 4391
9. 10.1259/bjr.2015017110.1259/bjr.20150171 ↗
10. 10.1259/bjr.2015017010.1259/bjr.20150170 ↗
11. 10.1517/17425247.2015.104953010.1517/17425247.2015.1049530 ↗
12. Elengoe A · J Biotechnol Lett · 2013 · 4 · 45
13. 10.3109/10717544.2014.91676510.3109/10717544.2014.916765 ↗
14. Akhtar MJ · Int J Nanomedicine · 2012 · 7 · 845
15. Chung H · Appl Biol Sci · 2013 · 110 · 7625
16. 10.1080/21691401.2017.134794110.1080/21691401.2017.1347941 ↗
17. Florento L · Int J Biomed Sci · 2012 · 8 · 7610.59566/IJBS.2012.8076 ↗
18. 10.1080/21691401.2017.140801910.1080/21691401.2017.1408019 ↗
19. 10.1080/21691401.2016.120225710.1080/21691401.2016.1202257 ↗
20. 10.1111/jcmm.1218810.1111/jcmm.12188 ↗
21. 10.2147/IJN.S8395310.2147/IJN.S83953 ↗
22. 10.1080/21691401.2017.129064310.1080/21691401.2017.1290643 ↗
23. Rupnow BA · Cancer Res · 1998 · 58 · 1779
24. 10.1038/sj.onc.120481510.1038/sj.onc.1204815 ↗
25. 10.3109/0284186740912988010.3109/02841867409129880 ↗
26. 10.5772/5579510.5772/55795 ↗
27. 10.18632/oncotarget.2167810.18632/oncotarget.21678 ↗
28. 10.3390/ijms1801012010.3390/ijms18010120 ↗
29. Liu G · Int J Nanomedicine · 2015 · 10 · 6075
30. 10.1016/j.biomaterials.2012.05.04710.1016/j.biomaterials.2012.05.047 ↗
31. Su XY · Cancer Biol Med · 2014 · 11 · 86
32. 10.1016/j.canlet.2014.02.00610.1016/j.canlet.2014.02.006 ↗
33. 10.1667/RR1984.110.1667/RR1984.1 ↗
34. 10.1259/bjr/5944883310.1259/bjr/59448833 ↗
35. 10.1016/j.rpor.2010.09.00110.1016/j.rpor.2010.09.001 ↗
36. 10.1007/BF0270448110.1007/BF02704481 ↗
37. 10.1016/j.radphyschem.2014.04.03310.1016/j.radphyschem.2014.04.033 ↗
38. 10.4236/wjnse.2012.2100510.4236/wjnse.2012.21005 ↗
39. 10.15171/apb.2015.04910.15171/apb.2015.049 ↗
40. 10.1186/1756-9966-30-8710.1186/1756-9966-30-87 ↗
41. Baharara J · Avicenna J Med Biotechnol · 2016 · 8 · 75
42. 10.3390/molecules2002269310.3390/molecules20022693 ↗
43. 10.1186/1471-2121-14-3210.1186/1471-2121-14-32 ↗
44. 10.1016/j.colsurfb.2016.02.04310.1016/j.colsurfb.2016.02.043 ↗